Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.50 -0.07 (-0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Cash & Current Investments (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) reported Cash & Current Investments of $788.49 million for Q2 2026, down 1.5% from $800.14 million a year earlier but up 20.7% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Sarepta Therapeutics posted Cash & Current Investments of $939.65 million, down 30.6% from FY2024.

  • Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -13.6% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $1.35 billion in FY2024 (-19.9%), $1.69 billion in FY2023 (-15.8%), $2.01 billion in FY2022 (-5.5%) and $2.13 billion in FY2021 (+9.1%).
  • Five-year quarterly Cash & Current Investments spans a low of $522.76 million in Q1 2025 and a high of $2.13 billion in Q4 2021.
  • Year over year, Cash & Current Investments gained in 1 of the last eight quarters, with an average decline of 24.4%.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2022 (growth of 30.0%); the low point was Q1 2025 (a decline of 62.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $653.24 million (Q1 2026), $939.65 million (Q4 2025) and $851.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Sarepta Therapeutics 1.85 Bn -1.38 Bn 251.87 Mn 788.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 788.49 Mn
Mar 31, 2026 653.24 Mn
Dec 31, 2025 939.65 Mn
Sep 30, 2025 851.02 Mn
Jun 30, 2025 800.14 Mn
Mar 31, 2025 522.76 Mn
Dec 31, 2024 1.35 Bn
Sep 30, 2024 1.20 Bn
Jun 30, 2024 1.46 Bn
Mar 31, 2024 1.39 Bn
Dec 31, 2023 1.69 Bn
Sep 30, 2023 1.75 Bn
Jun 30, 2023 1.88 Bn
Mar 31, 2023 1.90 Bn
Dec 31, 2022 2.01 Bn
Sep 30, 2022 2.09 Bn
Jun 30, 2022 1.95 Bn
Mar 31, 2022 2.02 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 1.61 Bn
API Access

Sarepta Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SRPT&period=max&api_key=YOUR_API_KEY